Discontinuation of therapy in inflammatory bowel disease: Current views

doi:10.12998/wjcc.v12.i10.1718

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2615)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

184

HTML

1608

Figures (1-1)

162

Tables (1-1)

175

Sum=2129

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

122

Download

268

Sum=390

Apr 6, 2024 (publication date) through Nov 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Apr 6, 2024; 12(10): 1718-1727
Published online Apr 6, 2024. doi: 10.12998/wjcc.v12.i10.1718

Full Size Figure Download Figure

Figure 1 Possible predictive factors of disease relapse after withdrawal of therapy in inflammatory bowel disease patients. CD: Crohn’s disease; CRP: C-reactive protein; TNF: Tumor necrosis factor; UC: Ulcerative colitis.

Citation: Meštrović A, Kumric M, Bozic J. Discontinuation of therapy in inflammatory bowel disease: Current views. World J Clin Cases 2024; 12(10): 1718-1727
URL: https://www.wjgnet.com/2307-8960/full/v12/i10/1718.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i10.1718